October 10, 2012
The Centers for Disease Control and Prevention (CDC) hosted a Clinician Outreach and Communication Activity (COCA) Conference Call yesterday to discuss the multi-state investigation of fungal meningitis among patients who received an epidural steroid injection.
During the call, CDC experts reviewed current epidemiology of the outbreak, described clinical presentation and features of fungal meningitis and reviewed the CDC’s recommended treatment guidance. Click here to access the recorded call audio and transcript.
All health care providers should note that New England Compounding Center (NECC) in Framingham, Massachusetts—the supplier of the epidural steroid associated with the cases of fungal meningitis—has issued a voluntary recall of all of the drugs the company has provided. The CDC and the US Food and Drug Administration (FDA) recommend that all health care professionals discontinue the use of any product produced by NECC until further information is available.
For more information about the outbreak click on the following CDC resources:
ASCA members who have been approached by patients or members of the media and would like assistance with their response should click here